Search Close Search
Search Close Search
Profile Picture for Aronin

Neil Aronin, MD

Professor of Department of Medicine and the RNA Therapeutics Institute, Division Chief of Endocrinology, Higgins Family Professor of Neuroscience

Research Focus - Therapeutic Development in Neurodegenerative Diseases

  • Developing therapeutics for Huntington’s disease using
    • RNA interference
    • genome editing 
  • Collaboration with University of Texas, San Antonio to investigate genetic mutations and susceptibility loci in pheochromocytoma

Representative Publications

  • Qin Y, Yao L, King EE, et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet. 2010;42(3):229-233. Read Publication

In the News

  • Dean Flotte testifies at congressional hearing in support of gene therapy development

    Dean Flotte testifies at congressional hearing in support of gene therapy development

    Dean Flotte testified in support of policies that would encourage and accelerate gene therapy for rare diseases, in a Feb. 29 hearing before the House Committee on Energy and Commerce’s Subcommittee on Health.

    Read more
  • MD/PhD student using NIH award to study onset of Huntington’s disease

    MD/PhD student using NIH award to study onset of Huntington’s disease

    MD/PhD student Jillian Belgrad has received an award from the National Institute of Neurological Disorders and Stroke to study the pathology that drives the development of Huntington’s disease symptoms.  

    Read more
  • Atalanta Therapeutics founded by UMass Medical School and three faculty members

    Atalanta Therapeutics founded by UMass Medical School and three faculty members

    Atalanta Therapeutics, a biotech founded by UMass Medical School and three faculty research scientists to pioneer treatment options for neurodegenerative diseases, has launched with financing by venture capital fund F-Prime Capital and strategic collaborations with Biogen and Genentech.

    Read more
  • Yasaman Gholamalipour awarded fellowship by Huntington’s Disease Society of America

    Yasaman Gholamalipour awarded fellowship by Huntington’s Disease Society of America

    UMass Medical School postdoctoral associate Yasaman Gholamalipour, PhD, was awarded the Huntington’s Disease Society of America Berman-Topper Family HD Career Development Fellowship for 2020.

    Read more
  • UMass Chan scientists mark progress on Huntington’s disease research

    UMMS scientists mark progress on Huntington’s disease research

    Neil Aronin, MD, led an afternoon of presentations detailing advances made by scientists at UMass Medical School in the quest to find a treatment for Huntington’s disease. CHDI Foundation President Robi Blumenstein accepted a plaque in recognition of the foundation’s $13 million in support of Huntington’s research at the medical school.

    Read more